South San Francisco, CA
ArsenalBio’s mission is to develop efficacious and safe cellular therapies for patients with chronic diseases, initially cancer.
arsenalbio.comThese are collections ArsenalBio is a part of. Click on the collection name to view similar companies.
Series C
$325,000,000
Series B
$220,806,682
Series A
$85,000,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on ArsenalBio.